ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> New York City Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: New York City Personal Injury Lawyer

Clinical Trials Funded by Pharmaceutical Industry more likely to Report Positive Results

By Paul Napoli

ADVERTISEMENTS

August 2, 2010

A study of clinical drug trials found that those funded by the pharmaceutical industry were more likely to report positive outcomes than were trials funded by other sources.

Researchers examined 546 clinical drug trials conducted between 2000 and 2006 listed in the registry at www.ClinicalTrials.gov. Their analysis showed that industry funded trials reported a favorable outcome 85% of the time, compared to 50% favorable outcomes for government-funded trials and 72% favorable outcomes for trials funded by nonprofits or non-federal organizations.

Of nonprofits and non-federal studies, nearly half were the recipients of drug industry contributions and reported positive outcomes 85% of the time, while those without any such contributions reported favorable results only 61% of the time.

"While we cannot specifically point to which factors contribute to the association between funding source and positive result reporting, our findings speak to the need for more disclosure of all elements of a study," said Florence Bourgeois, MD, MPH, of Children's Hospital Boston in a news release. "Publication bias is likely a contributing factor, but there may be many more, including biases in study design, patient selection, data analysis and results reporting."

The clinical trial review entitled 'Outcome Reporting among Drug Trials Registered in ClinicalTrials.gov' by Florence T. Bourgeois, MD, MPH; Srinivas Murthy, MD; and Kenneth D. Mandl, MD, MPH appears in the August 3, 2010 issue of the Annals of Internal Medicine.

Researchers also found that drug trials funded by pharmaceutical industry were less likely to be published within 2 years of study completion.

The National Institute of Child Health and Human Development and National Library of Medicine funded the study.

The U.S Food and Drug Administration (FDA) uses results of clinical drug trials in the approval process and regulation of drugs.

Originally posted at InjuryBoard by Paul Napoli

Full post as published by New York City Personal Injury Lawyer on August 02, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.003 secs (from cache 11/03/26 10:25:21)